Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use
HIV-1 中枢神经系统发病机制和香烟使用的细胞外囊泡和细胞外 RNA 生物标志物
基本信息
- 批准号:10217079
- 负责人:
- 金额:$ 63.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-30 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAffectAnimal ModelAstrocytesAttentionBackBenchmarkingBiologicalBiological MarkersBiologyBrainCD4 Positive T LymphocytesCatalogsCategoriesCell CountCellsCentral Nervous System DiseasesCerebrospinal FluidDiagnosisDiagnosticDiseaseDisease modelGeneral PopulationGoalsHIVHIV antiretroviralHIV-1HIV-associated neurocognitive disorderHumanIndividualInflammationLearningLiquid substanceLiteratureLongevityMeasurementMicroRNAsMicrogliaModelingMolecular ProfilingMorbidity - disease rateMorphologic artifactsNerve DegenerationNeuraxisNeuronsPathogenesisPhenotypePlasmaPopulationProcessRNARNA analysisReproducibilityResearchRoleSamplingSmokingSubstance Use DisorderTechniquesTechnologyTestingTimeTissue SampleTissuesTobacco smoking behaviorTobacco useUntranslated RNAValidationVesicleViral Load resultantiretroviral therapybody systembrain tissuecandidate identificationcandidate markercigarette smokecigarette smokingcircular RNAcohortcomorbiditycomparativeextracellularextracellular vesiclesimprovedinnovationnervous system disordernonhuman primatenovelnovel markerprognosticsample archivesenescencetooltranscriptome sequencingvirology
项目摘要
ABSTRACT
The HIV-associated neurocognitive disorders (HAND) and other neurologic disorders are predicted to affect
a majority of HIV-infected individuals at some time during the lifespan. These disorders occur despite effective
virologic suppression by antiretroviral therapy (ART). Yet few established biological markers. Recalling that
plasma biomarkers developed for AIDS (viral load and CD4+ T cell count) were essential in developing
treatment paradigms for AIDS, an intensified research focus on biomarkers of neurologic disease is warranted.
Improved biomarkers may be particularly important when substance use disorders (SUDs) are comorbid with
HIV disease. Among HIV+ individuals, cigarette smoking is several times more prevalent than in the general
population and contributes to inflammation and senescence processes that exacerbate pathogenesis in
multiple organ systems. Promising classes of biomarkers include stable extracellular RNAs (exRNAs), a
portion of which are packaged into extracellular vesicles (EVs) that can leave tissue such as brain to be
found in easily accessed biological fluids. These entities receive increasing attention as markers of neurologic
disease because of roles in neurodegeneration and (for EVs) because they can be traced back to a cell or
tissue of origin. Two categories of exRNA are particularly attractive because of their extraordinary stability:
microRNAs (miRNAs) and circular RNAs (circRNAs). miRNAs have been studied in HIV disease and SUDs,
but not in EVs of brain tissue, and almost nothing is known about circRNAs in HIV-1 pathogenesis or SUDs. In
this project, we will develop a catalog of biomarkers of HIV-1 pathogenesis and cigarette use and identify how
cigarette use may complicate interpretation of biomarker tests. Archived samples from a well characterized
animal model and human cohorts will be tested to identify and validate candidate biomarkers. Our expertise is
in HIV-1 disease and animal models; biomarkers of neurologic disease; EV techniques and biology; and
noncoding RNAs. We will first use a novel tissue EV isolation technique to seek candidate molecular
signatures of EVs and exRNA in brain tissue (Aim 1), and then investigate EV and exRNA signatures in
matched, longitudinally collected cerebrospinal fluid and blood plasma (Aim 2). Importantly, Aim 3 investigates
human samples in parallel. the project will address current gaps in the literature in rigorous and reproducible
fashion by ruling out common artifacts of EV and exRNA analysis and through cutting edge confirmation of the
identity of isolated EVs. Overall, we hypothesize that brain-derived EVs and their most stable exRNA
cargo, miRNAs and circRNAs, serve as biomarkers of HIV-associated neurologic disorders. Since some
markers will also be associated with cigarette smoking, tobacco use will be investigated for possible interfering
effects on measurement of neurologic disease biomarkers.
摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Kenneth W Witwer其他文献
Kenneth W Witwer的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Kenneth W Witwer', 18)}}的其他基金
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates
exRNA 载体的新型分离方法:细胞外囊泡、脂蛋白颗粒和蛋白质聚集体
- 批准号:
9975112 - 财政年份:2019
- 资助金额:
$ 63.91万 - 项目类别:
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates
exRNA 载体的新型分离方法:细胞外囊泡、脂蛋白颗粒和蛋白质聚集体
- 批准号:
10483185 - 财政年份:2019
- 资助金额:
$ 63.91万 - 项目类别:
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates
exRNA 载体的新型分离方法:细胞外囊泡、脂蛋白颗粒和蛋白质聚集体
- 批准号:
10470432 - 财政年份:2019
- 资助金额:
$ 63.91万 - 项目类别:
Novel Separation Methods for exRNA Carriers: Extracellular Vesicles, Lipoprotein Particles, and Protein Aggregates
exRNA 载体的新型分离方法:细胞外囊泡、脂蛋白颗粒和蛋白质聚集体
- 批准号:
9812105 - 财政年份:2019
- 资助金额:
$ 63.91万 - 项目类别:
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use
HIV-1 中枢神经系统发病机制和香烟使用的细胞外囊泡和细胞外 RNA 生物标志物
- 批准号:
9978799 - 财政年份:2018
- 资助金额:
$ 63.91万 - 项目类别:
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use
HIV-1 中枢神经系统发病机制和香烟使用的细胞外囊泡和细胞外 RNA 生物标志物
- 批准号:
10456790 - 财政年份:2018
- 资助金额:
$ 63.91万 - 项目类别:
Extracellular Vesicle and Extracellular RNA Biomarkers of HIV-1 Central Nervous System Pathogenesis and Cigarette Use
HIV-1 中枢神经系统发病机制和香烟使用的细胞外囊泡和细胞外 RNA 生物标志物
- 批准号:
9788410 - 财政年份:2018
- 资助金额:
$ 63.91万 - 项目类别:
Extracellular Vesicle-Mediated Immunomodulation in HIV Infection and Nicotine Abuse
HIV 感染和尼古丁滥用中细胞外囊泡介导的免疫调节
- 批准号:
9086347 - 财政年份:2015
- 资助金额:
$ 63.91万 - 项目类别:
International Society for Extracellular Vesicles - Education Day & Meeting
国际细胞外囊泡学会 - 教育日
- 批准号:
8910966 - 财政年份:2015
- 资助金额:
$ 63.91万 - 项目类别:
Circulating Cellular and Extracellular Noncoding RNAs in HIV-1 Elite Suppression
HIV-1 Elite 抑制中的循环细胞和细胞外非编码 RNA
- 批准号:
8541944 - 财政年份:2013
- 资助金额:
$ 63.91万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 63.91万 - 项目类别:
Research Grant














{{item.name}}会员




